Daily Shmutz | COVID-19  / Malicious Medical Quackery | 11/28/25

COVID-19  / Malicious Medical Quackery 

[Ed.:  FEAR YOUR DOCTOR!  Medicine is a disgraced profession.  The Hippocratic Oath is no longer applicable…  They cannot (and must not) be trusted any longer!  

Cultivate Nosocomephobia and iatrophobia.  Spread ‘vaccine hesitancy’! How Bad is My Batch?  Enter your batch number(s) and find out.  Then take action and purge yourself of this shit to the extent possible. It’s do-able! 

If you know someone injured by the jabs, direct them to humanitysuit.com to become a plaintiff.  Another great legal resource is: Freedom Council  https://freedomcounsel.org;  For Vaccine Exemptions: https://www.sirillp.com/vaccine-exemption-attorneys/ . 

RESOURCE: VACCINE INFO COURSE All material from the course has been transferred to telegram.  You can access everything here]

DIED SUDDENLY: Official Documentary Film   [1:17:21]

 

Inside mRNA Vaccines – The Movie   [1:00:59]

Premiered Aug 11, 2025

This film explores the unprecedented global rollout of mRNA vaccine technology. www.insidemrnavaccines.com

00:00 Intro

02:53 Surgeon Joel Wallskog’s health issues

06:21 Operation Warp Speed initiative

06:38 Former CDC Director on mRNA vaccines

07:35 Regulators’ safety assessment

08:09 Calls to pause mRNA vaccines

09:32 mRNA researcher Robert Malone

12:56 Pathologist Ryan Cole on COVID vaccination

14:14 Cardiologist Aseem Malhotra on heart health

14:37 Cardiologist Peter McCullough on side effects

17:28 Scientist Jessica Rose on vaccine concerns

18:41 Critical care specialist Paul Marik on patient community

21:17 Explaining mRNA

23:45 How mRNA vaccines work

27:06 Spike protein and possible effects

30:57 Pathologist Arne Burkhardt’s biopsy findings

32:49 Health agencies’ safety stance

33:38 Vaccination in pregnancy and children

34:22 Artist Jessica Sutta’s health issues

39:03 Future uses of mRNA technology

42:55 Tobie Vergara’s health issues

45:12 History of mRNA vaccines

46:44 Modified mRNA technology

48:40 mRNA research status in 2017

49:07 Toxicity concerns in 2017

49:33 Progress in mRNA technology

49:50 mRNA vaccines during the pandemic

55:41 Support for post-vaccination syndrome

57:06 Doctors offering assistance

[Ed.: Other vaccine controversies include:

1. How the vaccines caused the paralysis of polio

2. How vaccines caused sudden infant death syndrome (SIDS)

3. How vaccines cause brain damage, but we call it autism

4. How we covered up brain damage and made it a mental condition

 

Bombshell Vax vs. Unvax Study Finally Sees the Light of Day — And the Results Are Staggering

[Ed.:  An Inconvenient Study  Full Movie  [1:20:36]

Here is the link to the documentary An Inconvenient Study, which premiered tonight at the Malibu Film Festival.  It is the brilliant true story of the suppression of a vaxed vs unvaxed children’s study and the Henry Ford Health Center–suppressed because it showed over several years 3-6 TIMES the incidence of chronic illness between children who had even ONE childhood vaccine compared with children compared with children who had NO vaccines.  PLUS there was ZERO autism, ADHD and a couple of other things in the unvaxed cohort.

Watch the entire video and be sure to share it with everyone you think SHOULD KNOW about what it shows!

 

Vaccines and Adjuvants: Aluminum    DR. ROBERT W. MALONE

Just the facts, M’aam.

NOV 28, 2025

Are all vaccines similar, and what ingredients are in vaccines?

Each approved vaccine is a unique mixture of both ingredients and manufacturing processes. From a regulatory standpoint, vaccine products are a combination of ingredients, manufacturing process, process controls (including release testing), and supporting safety and efficacy/effectiveness testing. The repeated assertion that all vaccines are safe and effective is mere propaganda. Each licensed vaccine product has its own profile of risks, benefits, pharmacology, immunology, and other characteristics. In general, a vaccine “final drug product” consists of antigens, adjuvants, preservatives (in many cases), stabilizers and other “excipients”, surfactants, residuals (eg permitted contaminants), a diluent, and in some cases adulterants (contaminants at levels that are not permitted).

Preservatives are included in multi-dose vials to prevent bacterial or fungal contamination after the vial is opened. The most commonly used preservative is 2-phenoxyethanol, while thimerosal (containing ethylmercury) was historically used but is no longer present in most routinely used vaccines in the U.S.

Stabilizers protect the vaccine during manufacturing, storage, and transport by preventing chemical degradation and preventing components from sticking to the vial. Common stabilizers include sugars (like sucrose or lactose), amino acids (such as glycine), gelatin, and proteins like recombinant human albumin.

Surfactants are used to keep all ingredients evenly mixed in the liquid formulation, preventing clumping or settling. These are also found in some foods, such as ice cream.

Residuals are trace amounts of substances left over from the manufacturing process, such as egg proteins (from egg-based production), yeast, antibiotics (like neomycin or polymyxin B), or formaldehyde used to inactivate pathogens.

Diluents, typically sterile water or saline, are used to reconstitute freeze-dried vaccines or adjust the concentration before administration.

For the sake of discussion, vaccine products can be divided into three general categories.

1. Live Vaccines

Classically, “live” vaccines are essentially replication-competent viruses, bacteria, or potentially other replication-competent biological material. Simple examples include the oral polio vaccine, the yellow fever vaccine, the smallpox vaccine, and the Tuberculosis vaccine (BCG). A more recent example of this category is the “Flumist” influenza virus vaccine. In all of these cases, the patient is offered a product that actually infects them in some way, but – assuming that they have a “normal” properly functioning immune system – will not cause clinical disease. If the patient is immunosuppressed in some way, all bets are off. In the case of “live” vaccines, dosage, purity, identity, and “titer” of the product are critical. To illustrate this with a simple example, if you take multiple doses of yellow fever vaccine in close succession, you will get clinical yellow fever, and it can kill you. In general, “live” vaccines are the most effective, as they most closely mimic actual infection by a pathogen. However, they do cause the cells and tissues of your body to actually manufacture foreign proteins, similar to gene therapy-based vaccines.

2. Dead Vaccines.

“Dead” vaccines were originally prepared by taking a “live” replication-competent agent (virus or bacteria), growing it in some sort of material that will support replication (fermentation broth, cell culture, or fertile/embryonated chicken eggs for example) and “killing” or inactivating it in some way, typically by adding a chemical that would either break up the agent into its components, or damage its genome so that it could no longer replicate. One major problem with these types of products is purity, as this category is prone to contamination coming from the material used to support replication of the pathogen. The early anthrax vaccines used by the US Military during “Desert Storm” were notoriously “dirty” or contaminated with material that had nothing to do with the parts of the killed anthrax that were intended to be included in the product. Over time, various methods have been developed to produce much purer “antigens” or immunogenic components (including the use of recombinant DNA together with fermentation and advanced purification technology), but the paradox has been that as the preparations became purer, their “immunogenicity” was reduced. Essentially, the impurities were biologically active and often increased the adaptive (and innate) immune response to the intended “antigen” from the pathogen. This relates to the topic at hand, that being the use of “adjuvants” in vaccines. A related point is that, in the case of modern “subunit” vaccines produced using recombinant DNA technology, the biologically active “antigen” is produced outside your body and then injected. This is very different from the next and newest category of vaccines and technologies.

3. Gene Therapy-based Vaccines

The newest (third) category involves the use of recombinant DNA and/or gene therapy technologies to cause your body to manufacture some part of a pathogen, which, when presented to your immune system by your own cells, causes your body to mount an immune response (innate and/or adaptive) to the foreign protein derived from a pathogen. In many ways, this is similar to the first category, live attenuated vaccines. In the case of live attenuated vaccines, a weakened version of the pathogen is injected (or swallowed) and it replicates in your body. In the case of gene therapy-based vaccines, either a recombinant virus (such as an adenovirus) or a non-viral gene delivery formulation (mod mRNA or DNA) is administered, and this causes your body to produce a part of the pathogen (such as the spike protein from SARS-CoV-2). Another variant of this involves engineering the vesiculovirus (VSV) to display an Ebola virus protein on its surface – this is the Merck VSV Ebola vaccine. In that case, the VSV acts both as a gene therapy vector producing a specific adaptive immune response to Ebola, and also triggers a strong innate immune response. Up for discussion in that case is which is the more important active component. The latest version of gene therapy tech used for vaccination involves self-replicating RNA vectors based on alphaviruses.

In the case of the lipid nanoparticle-delivered mod mRNA vaccines, the inclusion of small DNA fragments derived from the bacterial DNA used to make the mod mRNA is probably a form of an adjuvant, much like other adjuvants commonly used with “killed” vaccines.

Adjuvants and Vaccines

What is an adjuvant? Quite simply, a vaccine adjuvant is any substance or compound added to a vaccine to enhance the body’s immune response to the antigen (the part of the vaccine that mimics the pathogen). This broad definition underscores the “anything goes” nature of adjuvants. You can find a pretty comprehensive list of known adjuvants here. This list was compiled by vaccine experts from both DoD and NIH/NIAID who were friends of mine, back in the days when I was very involved in AIDS vaccine development. It used to be available for download on the NIH website, but has since been removed. Fortunately, I kept a copy and have now made it available for downloading. It is a bit dated, but still represents the most comprehensive summary of adjuvants that I am aware of.

Adjuvants are used by researchers and the vaccine industry to stimulate adaptive immune responses to pathogen-specific antigens. At a simplistic level, you can think of an adjuvant as something that provides a “danger signal” to the immune system, causing it to respond to a foreign molecule when it otherwise might not respond. Typical adjuvants act to increase the strength and duration of the immune response, allow lower doses of antigen to be effective (dose-sparing), broaden the immune response (e.g., against drifting viral strains), direct the type of immune response (e.g., favor antibody production or T-cell activation), and improve overall vaccine efficacy in populations with weaker responses (infants, elderly, immunocompromised).

As discussed above regarding the category of “dead” vaccines, industry experience has been that, in general, the more pure the vaccine antigen, the less active it is for eliciting a robust adaptive (B and T cell) immune response. In other words, An adjuvant is an immune-response “booster” deliberately included in some vaccines to make them work better.

General categories of adjuvants include the following:

• Aluminum salts (alum) – oldest and most widely used (in many childhood vaccines like DTaP, hepatitis B)
• Oil-in-water emulsions – e.g., MF59 (in some flu vaccines for elderly), AS03 (in pandemic flu vaccines)
• Liposome-based – e.g., AS01 (in Shingrix shingles vaccine and some malaria vaccines)
• TLR agonists – e.g., CpG 1018 (in Heplisav-B hepatitis B vaccine), MPL (in Shingrix)
• Saponin-based – e.g., QS-21 (in Shingrix and some COVID/malaria vaccines)
  

Aluminum Adjuvants and Vaccines

Various forms and formulations of aluminum salts are used as vaccine adjuvants. These preparations are among the oldest and most widely used adjuvants. These are NOT the same as powdered metallic aluminum or free aluminum ions, which ARE highly toxic to humans.

• Almost every inactivated or subunit vaccine given to infants and young children contains aluminum (except pneumococcal conjugates and Hib PedvaxHIB).
• Many novel or experimental adjuvants employ aluminum salts together with other agents (liposomes etc.)
• Most live vaccines and modern conjugate/mod mRNA vaccines do not contain aluminum.
  

Clinical Syndromes associated with aluminum powder, aluminum ion or injected aluminum exposure toxicity include

1. Dialysis encephalopathy (dialytic dementia)
   1. Caused by high aluminum in dialysis fluid pre-1980s
   2. Symptoms: speech disturbance, seizures, myoclonus, psychosis
   3. Now extremely rare due to water treatment standards
      

1. Parenteral Neonatal (PN) Aluminum Toxicity

1. 1. Preterm infants exposed to 4–5 μg/kg/day IV aluminum via parenteral nutrition show neurodevelopmental and bone toxicity.
   2. These findings led to FDA aluminum limits for parenteral nutrition solutions.
   3. Vaccine-day aluminum doses, although differing in chemical structure from free aluminum ions, can be orders of magnitude higher per kg than PN limits.
      

1. Aluminum-induced bone disease (osteomalacia)

1. 1. Seen in long-term parenteral nutrition or dialysis patients
   2. Fracturing bone pain, hypercalcemia, resistance to vitamin D
      

1. Pulmonary fibrosis / aluminosis

1. 1. From chronic intense inhalation of aluminum powder
   2. Rare occupational disease
      

1. Macrophagic myofasciitis (MMF)

1. 1. Persistent aluminum-containing granulomas at intramuscular injection sites (mostly deltoid)
   2. Symptoms in many MMF patients: chronic myalgias, fatigue, and cognitive difficulties.
   3. Detected in some patients with myalgia, fatigue, and cognitive issues
   4. Causal link to systemic symptoms is not universally accepted
   5. Muscle biopsies show aluminum-loaded macrophages (MMF lesions) at prior vaccine sites years later. This demonstrates long-term persistence of aluminum adjuvants in human tissue.
      

Continue reading

 

Over 23,000 Canadians IED while on wait-lists for medical care under socialized heatlh system: report

The study compiled the data using freedom-of-information requests submitted to more than 40 provincial and territorial health agencies.

NOV 26, 2025  The Post Millennial

Canada recorded at least 23,746 patient deaths while individuals were waiting for surgeries or diagnostic procedures between April 2024 and March 2025, according to a new report from public policy group SecondStreet.org.

The figure marks a three percent increase over the previous year and brings the total number of reported wait-list deaths since 2018 to more than 100,000, CTV News reports.
The organization compiled the data using freedom-of-information requests submitted to more than 40 provincial and territorial health agencies. Several jurisdictions released only partial numbers, while Alberta and areas of Manitoba provided none.
As a result, the report states the true national total is likely higher. “No government reports publicly on patients dying on waiting lists,” said SecondStreet.org president Colin Craig.
Ontario reported the highest number of deaths at 10,634, including more than 9,100 cases involving patients who died before receiving or being scheduled for surgery. Quebec recorded 6,290 deaths, while British Columbia reported 4,620. Other provinces reported smaller totals ranging from 121 in New Brunswick to 727 in Nova Scotia. Manitoba listed 215 deaths, though the data set was incomplete.

The report includes multiple examples of patients who died while waiting for care. It highlights the case of Manitoba resident Debbie Fewster, who was advised in July 2024 that she required heart surgery within three weeks. She waited more than two months and died on Thanksgiving Day. Similar cases were previously documented in Ontario and Alberta.
SecondStreet.org notes many of the deaths occurred among patients waiting for procedures aimed at improving quality of life—such as hip and knee replacements, cataract surgeries, and MRIs.
A significant portion involved potentially life-saving interventions, including cardiac care and cancer-related treatment. Ontario’s cardiac data showed 355 deaths among patients awaiting heart procedures, at least 90 of whom waited beyond recommended timelines.
Despite record levels of health spending, $244 billion from 2024 to 2025, with per-capita funding nearly triple that of the mid-1990s—the report argues system performance has not improved. It cites research indicating Canada continues to have fewer doctors, hospital beds, and MRI machines per capita than comparable universal health-care systems.

 

THE NO‑EXIT MENTAL HEALTH SYSTEM: THE FEDERAL GOVERNMENT PUTS YOU ON PSYCHIATRIC DRUGS AND NEVER LETS YOU OFF

November 26, 2025

The Federal Government is the largest funder of mental health services and psychiatric drugs, yet these same federal agencies that provide mental health services do not provide any information for safely getting off the drugs. AbleChild believes that as the largest supplier of psychiatric drugs, the federal government should also provide an “Exit plan” for deprescribing psychiatric drugs.

Medicaid and Medicare Part D treat psychiatric drugs as “must-cover” commodities: federal rules require drug plans to cover all or nearly all antidepressants and antipsychotics as protected classes, ensuring easy access and steady revenue for manufacturers. With Medicaid alone, antipsychotics generated more than 73 million prescription claims and  more than 6 billion dollars in one year, accounting for roughly 9% of all Medicaid drug spending and 10% of prescriptions.

This federal psychiatric drug infrastructure is one-way: it is built to initiate and maintain long-term drug exposure. There is no parallel requirement that any prescriber, clinic, or health plan design a personalized Exit plan before starting any psychiatric medications, and no federal benefit category that funds slow, labor-intensive taper support the way it funds prescription refills.

Regulators acknowledge serious risks associated with too many of the psychiatric drugs. For example, the Food and Drug Administration’s, (FDA) black-box warnings on antidepressants note increased suicidality risk in children, teens, and young adults, and require close monitoring when treatment is started or doses are changed. Large reviews of antidepressant withdrawal find that discontinuation symptoms are common—An alarming body of meta-analyses and large-scale surveys consistently demonstrates that between one-third and nearly one-half of patients prescribed psychiatric drugs experience withdrawal effects, with a significant portion enduring severe and drawn-out symptoms. For many, these reactions are far more than discomfort—they include incapacitating dizziness, unrelenting nausea, jarring electric-shock sensations, agitation, and relentless insomnia, often rivaling or overwhelming the original condition that led to treatment.

Beyond these physical and psychological torments, the risks escalate further. Withdrawal can trigger waves of suicidal thoughts and behaviors, with evidence linking severe discontinuation—particularly of antidepressants and opioids—to suicide attempts and completed suicides. Research documents the strong association between withdrawal and heightened aggression or violence, whether due to direct drug effects, physical desperation, or drug-seeking behavior fueled by protracted suffering. These dangers are not rare complications—they are consequences faced by a non-trivial share of those attempting to discontinue psychiatric drugs, and their impact on patient safety, public health, and the justice system is profound and underacknowledged.

Yet despite clear evidence that stopping psychiatric drugs can be medically complex and dangerous, U.S. law does not guarantee access to slow tapers, compounding, or close follow-up, when patients want to come off the drugs. A few specialty guidelines now outline careful benzodiazepine tapers and warn against abrupt cessation, but they are advisory documents, not enforceable rights. In practice, patients are routinely placed on medications with known withdrawal syndromes, while being left to navigate the exit alone or with minimal support when they try to stop.

Because coverage rules privilege pills, they tilt the entire system toward chronic drug dependence instead of time-limited, skill-building care. Analyses of Medicaid spending show billions flowing to antipsychotics and other psychotropics, while non-pharmacological interventions—peer support, psychotherapy, exercise programs, housing support—remain underfunded and harder to access, especially for low-income patients. For many people, the easiest treatment to start (a prescription) becomes the hardest to leave, not because of personal weakness, but because the addictive nature of the drugs, policy and payment are designed that way.

Labeling and drugging carry deep civil-liberty consequences. Once someone is coded with a psychiatric diagnosis and placed on powerful drugs, that record can influence everything from custody disputes to employment opportunities, firearm rights, and how police and courts interpret their credibility and autonomy. The FDA’s own warnings concede that some psychiatric drugs can increase agitation, impulsivity, or suicidality in subgroups, yet these same drugs are pushed as a default requirement to be considered “in treatment.”

In effect, a patient who accepts a psychiatric label and a prescription in today’s system risks trading long-term bodily sovereignty and legal standing for short-term empty promises of symptom relief. The state and insurers guarantee an on-ramp—coverage, formularies, aggressive screening—but refuse to build a safe, resourced off-ramp. Until there is a legal right to an Exit plan and public funding for non-drug options, “choice” in psychiatric treatment in the United States remains heavily one-sided, favoring lifelong medication over informed consent.  Here is AbleChild’s 10 point recommended federal psychiatric drug “exit plan.”

ABLECHILD RECOMMENDED FEDERAL PSYCHIATRIC DRUG “EXIT PLAN”

• Physicians must conduct all biological tests first to rule out any possible medical condition.
• Physicians must advise patients that the mental health diagnosis is not based in science and there is no abnormality in the brain that is the diagnosed psychiatric disorder.
• Physician must advise patient of alternative treatment other than drugs, ie. exercise, diet, and talk therapy.
• Physicians must advise patients that the pharmaceutical companies do not know how the recommended psychiatric drug works in the brain for the disorder.
• At first prescription written, physician must provide an anticipated “treatment” timeline. Start date and expected end date for each drug.
• With each prescription, physicians must provide written expectations with specific timeframes.
• Provide patient with written information about when prescription drug is anticipated to work and what specific possible life-threatening adverse events to be aware of for each prescribed drug.
• At first prescription, physicians should provide patients with return in-person appointment to review behavioral status and discussions about continuation or discontinuation of specific drugs.
• Physicians must provide detailed written information about withdrawing from each psychiatric drug and should be overseen by physicians on weekly basis.
• Three-, Six- and Nine-month physician follow-up recommend after withdrawal from all psychiatric drugs.

Be the Voice for the Voiceless

AbleChild is a 501(3) C nonprofit organization that has recently co-written landmark legislation in Tennessee, setting a national precedent for transparency and accountability in the intersection of mental health, pharmaceutical practices, and public safety.

What you can do.  Sign the Petition calling for federal hearings!

 

‘Stunning’: Only 1 in 7 Germans With Positive PCR Test Had COVID Infection   by Michael Nevradakis, Ph.D.

The authors of a new peer-reviewed study that identified an 86% false positive rate for COVID-19 PCR tests said their findings suggest a “significant overcounting” of COVID-19 infections during the pandemic. By the end of 2021, 92% of Germans had already acquired a natural infection, indicating near-universal immunity in the population.

NOVEMBER 26, 2025  Children’s Health Defense

Only about 1 in 7 positive PCR tests in Germany during the COVID-19 pandemic indicated an actual coronavirus infection that triggered an antibody response, according to a new peer-reviewed study.

Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense (CHD), called the study’s findings of an 86% false positive rate “stunning.”

The study also found that by late December 2020, when COVID-19 vaccines rolled out, about 25% of Germans had already acquired a natural infection. By the end of 2021, the figure rose to 92%, indicating near-universal immunity in the population.

PCR tests led to ‘significant over-counting’ of COVID infections

The study by three German researchers, published last month in Frontiers in Epidemiology, used two mathematical models to analyze how well PCR test results aligned with the results of blood tests for SARS-CoV-2 antibodies.

The findings were based on data obtained from accredited labs in Germany that handled about 90% of PCR tests in the country from March 2020 to early 2023, and also performed antibody (IgG) blood tests until May 2021.

The researchers — Michael Günther, Ph.D., Robert Rockenfeller, Ph.D., and Harald Walach, Ph.D. — said their models aligned data from PCR tests that detect “small bits of viral genetic material in the nose or throat,” and antibody tests that show if a person’s immune system “responded to an actual infection weeks or months earlier.”

They told The Defender:

“When we compared the number of PCR positives with later antibody results, only about 1 out of 7 PCR-positive people showed the kind of immune response that indicates a true infection. Under conservative assumptions, it could be closer to 1 out of 10.”

Their analysis also showed that by the end of 2021, “nearly everyone” in Germany had been “infected, vaccinated, or both.”

The 1 in 7 PCR test figure “almost perfectly” aligns with a year-end population-wide immunity rate of 92%, they said, according to the study’s mathematical model.

The researchers explained that antibody tests “tell us that a person was infected at some point in the past year or so,” while a positive PCR test result can indicate infection — or “brief exposure without infection, leftover viral fragments or detection at very low levels that never lead to illness.”

They said their study showed that only about 14% of PCR-positive tests corresponded to actual infections that triggered IgG antibodies — suggesting that PCR tests led to a “significant overcounting” of infections.

Mass PCR testing ‘increases the relative share of false positives’

Critics of official COVID-19 policies frequently cited the reliance on PCR tests and inconsistencies in the viral thresholds used to generate a “positive” test result.

Karl Jablonowski, Ph.D., senior research scientist at CHD, said PCR tests are an unreliable tool for detecting and tracking infectious disease outbreaks. He cited a 2006 incident at Dartmouth-Hitchcock Medical Center, where an alleged pertussis (whooping cough) outbreak led to 134 positive test results.

“Over 1,300 prescriptions of antibiotics were distributed and 4,500 people were prophylactically vaccinated” — even though there were “zero laboratory-confirmed cases.” The misuse of PCR testing led health officials to falsely declare an outbreak, he said.

A PCR test is “not a diagnostic test for a population,” Jablonowski said. “It is best used as a confirmatory test, essentially answering, ‘What virus has infected you?’ and not, ‘Are you infected?’”

The German researchers said their findings don’t indicate that PCR technology is “flawed as a laboratory method.” However, the study shows that the way in which PCR tests were used for mass testing during the pandemic “did not reliably indicate how many people were actually infected.”

They said PCR tests reliably detect viral DNA fragments, including in “extremely small amounts” that “pose no infection risk” — but not whether the virus is replicating in the body.

Positive results should not be used “as a proxy for infection,” because mass PCR testing “increases the relative share of false positives,” the researchers concluded.

Mass PCR testing led to ‘unnecessary social, economic and personal harms’

Governments’ reliance on PCR test results to track COVID-19 infection levels resulted in pandemic-related restrictions that contributed to “unnecessary social, economic and personal harms,” the researchers said.

Governments used PCR test results to justify strict restrictions, even though public health agencies had access to higher-quality antibody test data.

“Better information existed than what was communicated publicly,” the researchers said. This raised “serious questions about transparency and about whether policy was based on the most informative data available.”

Jablonowski said that in the early days of the pandemic, PCR tests likely provided a more accurate picture of the spread of infection as test kits were scarce, so they were used on those more likely to be infected.

But as tests became more readily available, “they were used on those with no symptoms and mandated for hospital admissions, air travel, employers and many other access-controlled activities,” Jablonowski said.

The authors of the German study said a more scientifically sound approach would have included more accurate data on PCR tests that showed results as a proportion of the number of tests performed, routine monitoring of antibody levels in the population and “transparent communication … clearly stating what PCR can and cannot measure.”

“This set of practices … should guide future public-health policy,” the researchers said.

German government documents leaked last year suggested the country’s official response to the COVID-19 pandemic was based on political objectives, and that Germany’s recommended countermeasures and restrictions often contradicted scientific evidence.

During a 2022 interview on Robert F. Kennedy Jr.’s “RFK Jr. The Defender Podcast,” mathematician Norman Fenton, Ph.D., said government officials across the world manipulated PCR test data to exaggerate the extent of the pandemic.

Jablonowski said the “hysteria of the mandated PCR tests prepared the population’s mindset for the mandated vaccinations to come. The tests had nothing to do with population health and everything to do with population control.”

PCR testing for COVID-19 is far less prevalent today than during the peak of the pandemic. However, the researchers said their study “matters today because the structural error it reveals — treating PCR positives as infections — has not been corrected.”

“As we face new pathogens, like bird flu, relying on PCR alone risks repeating the same mistakes,” the researchers said.

‘Polarized’ response, as results ‘challenge assumptions that shaped pandemic policy’

The researchers said they encountered “considerable difficulty” in getting their paper published. This included rejections by six other journals, out of which only two sent the manuscript for peer review.

These journals sought to “protect the prevailing narrative, rather than engaging with the core of our analysis,” the researchers said.

The researchers said that two of the original three reviewers for Frontiers in Epidemiology “withdrew from their assignments.” This forced the editor to recruit a fourth reviewer, which delayed the paper’s publication.

Response to the paper has been “polarized,” they said. “Some readers have welcomed the quantitative comparison of PCR and IgG data as overdue, while others have questioned the study’s implications or attempted to dismiss it without engaging with the underlying methodology.

This wasn’t surprising, “given that the results challenge assumptions that shaped pandemic policy,” they said.

Related articles in The Defender

• Even When It Came to Children, German Government Ignored Own Scientists to Impose Strict COVID Vaccine, Mask Mandates
• PCR Testing for Bird Flu ‘Will Only Serve to Raise False Case Count’ Critics Say
• Officials Manipulated COVID Data to Exaggerate Crisis, Mathematician Tells RFK Jr.
• CDC Changes Rules for Counting Breakthrough Cases, as More Fully Vaccinated People Test Positive
• WHO Finally Admits COVID-19 PCR Test Has a ‘Problem’

Michael Nevradakis, Ph.D.  Michael Nevradakis, Ph.D., based in Athens, Greece, is a senior reporter for The Defender and host of “The Defender In-Depth” on CHD.TV.

 

EXPOSED: “These people who we thought were on our side… how are they controlled?” Pharma Insider Claims Pharma Money Runs Through Trump’s Inner Circle   LIONESS OF JUDAH MINISTRY

Sasha Latypova breaks down the hidden profit networks shaping loyalty and influence at the highest levels.

NOV 26, 2025  Source: Sense Receptor

Pharma insider Sasha Latypova: “These people who we thought were on our side… how are they controlled?… Well, the Trump administration is heavily funded by pharma… Susie Wiles, Calley Means, these are major pharma lobbyists… and the Trumps have licensed their name to Trump to TrumpRx, so he’s getting licensing revenues.

“Also, Trump’s son, Don Jr., is on BlinkRx, yet another layer of that distribution where he’s getting a cut. Okay, so they’re directly profiting. And Howard Lutnick, he’s Commerce Secretary, is funding a vehicle to take BlinkRx and TrumpRx public so everyone can participate in that investment vehicle. And so that’s one mechanism by which everyone is controlled.”

This clip of Latypova is taken from a Weston A Price talk posted to X on November 17, 2025.

Partial transcription of clip

“Well, let me tell you first, as far as, you know, asking how are these people, how are these people who we thought were on our side and now not doing what they were promising to do, how are they controlled? Well, I, you know, as I can’t sit in their heads and I don’t know their backgrounds, I don’t know exactly how they’re controlled, but my guess is, what I can discern from publicly available information, Trump administration is heavily, heavily funded by pharma.

“And that’s not, I mean, every administration is heavily funded by pharma. It’s not unique to Trump, obviously. They funded Trump one, Biden, and Trump two. And Susie Wiles, Calley Means, these are major pharma lobbyists. Calley Means’ father is Nelson Rockefeller’s staffer, known globalist, right? Has a website writing about New World Order and global agenda.

“So what do you think Calley Means is doing there? And of course, the pharma lobby is a huge contributor funding Trump’s entire operation. And they’re profiting off of it.

“I also have written about it. So, for example, Trump just now made a deal with Pfizer. It’s being advertised as if, you know, I threatened them with tariffs, and they caved in, somehow. But as a result of this caving in, the Trump administration is allowing them to go sell drugs directly to the consumers. They’re eliminating the pharmacy benefits managers, and I’m not crying tears over that, but they’re eliminating the middleman and splitting the proceeds amongst themselves.

“So pharma gets a chunk, Trump family gets a chunk. Trump licenses their name to Trump to TrumpRx, so he’s getting licensing revenues. Trump is also Trump’s son, Don Jr. Is on BlinkRx. Yet another layer of that distribution where he’s getting the cut. Okay, so they’re directly profiting.

“Howard Lutnick, he’s Commerce Secretary, is funding a vehicle to take BlinkRx and TrumpRx public so everyone can participate in that investment vehicle. And so that’s one mechanism by which everyone is controlled. They’re allowed to profit off of this. They’re given position of power, and they’re allowed to profit off of this.

“That’s one very obvious mechanism of control. There may be others. Of course, Epstein files. We all want to see them. And that may be another mechanism of control.”

Full Video

 

IDF Lone Soldier Collapses From Sudden Cardiac Arrest and Is in Critical Condition

November 26, 2025  Jewish Breaking News

Katya thought she was going out for just another carefree night in Tel Aviv. The 21-year-old, a recently released Border Police (Magav) combat soldier and lone immigrant from Ukraine, was dancing in a city nightclub when she suddenly collapsed from a massive cardiac arrest. Friends say she had not been drinking or taking any substances. Paramedics from Magen David Adom shocked her heart three times on the club floor and managed to bring back a pulse after around ten minutes of clinical death, before rushing her to Ichilov Hospital in critical condition.

In the days since, Katya has been fighting for her life in intensive care. Doctors managed to stabilize her and began slowly reducing her sedation; she has started to wake up, but her condition is still described as serious, with real concern about potential brain damage caused by the extended period without oxygen. Physicians expect she will need a pacemaker implanted and then face a long, demanding rehabilitation process, both physical and cognitive.

The drama began when the music was still playing. One of her close friends, who was with her in the club, recalled that she simply dropped to the floor mid-evening. He checked whether she was responsive, heard a terrifying gurgling sound instead of an answer, and realized there was no pulse. Friends carried her outside, started CPR on the pavement, and continued until paramedics arrived and took over aggressive resuscitation.

From the first minutes, those around her insisted this was not a case of drugs or heavy drinking gone wrong. They told medical staff that she had not consumed alcohol or any other substance that night. Toxicology tests at the hospital later backed them up, coming back clean and deepening the mystery of how a healthy 21-year-old’s heart could simply stop in the middle of a night out.

Katya immigrated alone from Ukraine at age 14 through the Naale program, which brings teenagers to Israel to complete high school. She was taken in by a host family who treated her as a daughter and helped her build a life here. After school, she chose one of the toughest tracks in the IDF system: two years of service in the Border Police as a lone soldier, far from her biological family.

Just about two weeks before the collapse, she received her discharge from Magav. Like many released soldiers, she suddenly shifted overnight from full army care to the civilian maze of health insurance, National Insurance (Bituach Leumi), housing and work. According to her host family, she had not yet managed to complete the paperwork to re-activate her civilian health coverage and secure basic financial safety nets. That bureaucratic limbo has now crashed into the worst possible medical emergency.

Today, Katya’s mother is sitting beside her hospital bed in Tel Aviv. She flew in from Ukraine with almost nothing in hand, dropping everything to be with her daughter. Her Israeli host family describes the two women as essentially alone: no savings, no steady income, and no functioning safety net to cover rent, basic living costs, and the mounting bills that come with intensive care and rehab. “When she needs support the most, she has nothing,” the host mother told Israeli media, explaining that they are doing everything they can so the two do not collapse under the financial weight on top of the medical crisis.

Friends, former comrades and strangers who heard the story have begun to close that gap themselves. A crowdfunding campaign on the Israeli platform Giveback has been launched under the banner “Everyone for Katya,” aiming to fund her rent, daily living expenses, specialized treatment and rehabilitation, as well as her mother’s stay in Israel for as long as necessary. Israeli news outlets and social-media accounts have amplified the appeal, turning Katya into a symbol of how quickly a young immigrant soldier can go from dancing in a club to needing the entire community to keep her alive.

Fundraiser for Katya: https://giveback.co.il/project/88146 

There is a broader story here about lone soldiers and the narrow window between discharge and civilian life. During service, conscripts receive health care through the Defense Ministry and are outside the regular health fund system. After release, they are meant to rejoin or choose a health fund and update their status with Bituach Leumi almost immediately. In reality, many young men and women—especially those without parents in Israel—struggle to navigate the process quickly while also searching for work, housing and a new routine. When something goes catastrophically wrong in that gap, it can leave them exposed at the worst possible moment.

Katya’s case concentrates several layers of vulnerability: a young immigrant, a lone soldier, a discharged combat veteran, a daughter of a mother still living abroad, and a patient suddenly requiring intensive, long-term neurological and cardiac care. For many Israelis, especially those who have served or hosted lone soldiers, the story is hitting hard because it feels like a test of whether the country truly stands behind the young people who chose to stand guard for it.

 

Over 1,100 Studies Reveal 12 Natural Compounds With Potent Anti-Cancer Effects Across All Major Tumor Pathways  NICOLAS HULSCHER, MPH

Landmark analysis identifies 12 natural compounds with broad anti-cancer activity, consistently targeting core pathways such as cell death, immune evasion, metabolic dysfunction, and metastasis.

NOV 25, 2025

A landmark 2025 review titled, Natural anti-cancer products: insights from herbal medicine, published in Chinese Medicine, pulled together more than 1,100 scientific studies and uncovered something extraordinary: across cell, animal, and multi-omics research, 12 natural compounds repeatedly showed potent anti-cancer activity—triggering cancer cell death, blocking metastasis, cutting off tumor blood supply, disrupting tumor metabolism, and reversing drug resistance. Notably, the vast majority of this evidence comes from studies published since 2019, reflecting a rapid surge of new research in this field.

To build this analysis, they examined results from in vitro experiments (cancer cell lines), in vivo tumor models (mouse xenografts, orthotopic tumors, chemically induced cancers, zebrafish models), ex vivo mechanistic assays, and modern omics platforms including transcriptomics, proteomics, and metabolic profiling.

Their goal was to map how these compounds act at the molecular level. What emerged was a strikingly consistent pattern: a relatively small group of natural molecules repeatedly interferes with cancer’s core survival pathways — the very systems that support growth, spread, immune evasion, angiogenesis, and treatment resistance.

THE 12 NATURAL ANTI-CANCER COMPOUNDS

1. Apigenin (Chamomile)

• Helps immune cells detect tumors (reduces PD-L1)
• Slows growth signals inside cancer cells (inhibits PI3K/AKT, EGFR, ERK)
  Improves chemotherapy responsiveness (reduces MDR1/P-gp activity)
• Limits tissue invasion (suppresses NF-κB, MMP-2/9)
• Induces cell death through several pathways (apoptosis, autophagy, ferroptosis)

2. Artemisinin (Sweet Wormwood)

• Generates oxidative stress inside tumors (ROS, lipid peroxidation)
• Restricts blood vessel formation (anti-angiogenic)
• Slows cancer cell movement (reduces vimentin, N-cadherin)
• Helps counter drug resistance (affects STAT3, AKT, HSP90)
• Shows activity across many animal tumor models

3. Berberine (Coptis / Goldenseal)

• Disrupts major growth pathways (PI3K/AKT, HER2, TGF-β)
• Reduces tumor-fueling inflammation (NF-κB)
• Helps reverse drug resistance (P-gp, MRP1, NRF2)
• Lowers immune evasion signals (PD-L1)
• Reduces metastatic behavior (MMP-2/9)

4. Curcumin (Turmeric)

• Triggers cancer cell death (apoptosis, autophagy, ferroptosis)
• Lowers inflammation inside tumors (NF-κB, STAT3)
• Blocks blood vessel growth (VEGF inhibition)
• Helps reverse chemotherapy resistance (P-gp, BCRP)
• Reduces invasive behavior (Twist1, MMP-9, EMT markers)

5. Emodin (Rhubarb Root / Japanese Knotweed)

• Interferes with cancer cell communication (Wnt/β-catenin, STAT3, NF-κB)
• Initiates several types of cell death (necroptosis, ferroptosis)
• Disrupts cancer metabolism (GLUT1 reduction)
• Limits spread by reducing enzymes that break tissue barriers (MMP-2/9)
• Helps counter drug resistance (P-gp, GST)

6. EGCG (Green Tea)

• Slows growth by interrupting major pathways (PI3K/AKT/mTOR)
  Promotes programmed cell death (Bax↑, Bcl-2↓)
• Reduces inflammation (STAT3)
• Inhibits invasion and angiogenesis (MMP-2/9, VEGF)
• Decreases drug resistance (P-gp suppression)

7. Ginsenosides (Ginseng)

• Reduce metastatic behavior (EMT inhibition, MMP suppression)
• Improve immune responses (STAT3 downregulation)
• Promote cancer cell death (caspase activation)
• Help restore normal growth regulation (p53, PTEN)
• Some forms influence gut microbiota related to tumor microenvironments

8. Icariin / Icaritin (Horny Goat Weed)

• Support immune recognition of tumors (CD8+ T cells, CXCL9/10)
• Reduce PD-L1 (a key shield tumors use to hide)
• Inhibit tumor growth signals (PI3K/AKT)
• Counteract chemotherapy resistance (P-gp, MRP1)
• Improve cell adhesion and reduce invasiveness (E-cadherin upregulation)

9. Resveratrol (Grapes, Berries)

• Activates protective genes (p53)
• Reduces inflammation (NF-κB)
• Slows invasive behavior (vimentin↓, EMT↓)
• Initiates multiple cell death pathways (apoptosis, autophagy, ferroptosis)
  Shows synergy with conventional treatments

10. Silibinin (Milk Thistle)

• Slows growth signals (mTOR, STAT3)
• Reduces tumor blood vessel development (anti-angiogenic)
• Limits spread (Wnt/β-catenin inhibition)
• Supports mitochondrial function
• Decreases PD-L1 expression

11. Triptolide (Thunder God Vine)

• Very potent at low concentrations (nanomolar range)
  Blocks multiple tumor-promoting pathways (NF-κB, STAT3, AKT/mTOR)
  Lowers immune evasion signals (PD-L1, CD47)
  Promotes apoptosis and cell-cycle arrest

12. Ursolic Acid (Apples, Basil, Rosemary)

• Promotes cell death pathways (p53, ROS)
  Slows tumor growth (AKT/mTOR inhibition)
  Limits metastatic movement (CXCL12, FN1)
  Helps reduce drug resistance
  Activates stress pathways related to ferroptosis (NRF2 suppression)

Although the review does not provide detailed clinical trial outcomes, it assembles one of the most comprehensive collections of preclinical evidence ever compiled on how natural compounds act on cancer. Across cell studies, xenograft models, orthotopic tumors, and multi-omics analyses, the findings converge on a striking pattern: these molecules consistently disrupt the same core pathways that fuel tumor growth, immune evasion, metastasis, and treatment resistance.

Importantly, several of these compounds—such as curcumin, artemisinin derivatives, ginsenosides, icaritin, silibinin, and resveratrol—are no longer confined to laboratory research. Multiple early-stage and mid-stage clinical trials are already underway, and in the case of icaritin and certain ginsenosides, Phase II and Phase III studies are actively progressing. The scientific community is clearly beginning to take notice.

With cancer rates rising worldwide, these well-tolerated, multi-pathway natural compounds should be advanced into rigorous clinical testing to fully determine their therapeutic potential in human disease.

Nicolas Hulscher, MPH   Epidemiologist and Foundation Administrator, McCullough Foundation

Support our mission: mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.

[Ed.:  I’ve noticed that the Horny Goat Weed does not make you any hornier…]

 

BREAKING: Dr. Rima Laibow Calls Out RFK Jr. for Failing to Withdraw the Ultra-Deadly Covid Jabs   LIONESS OF JUDAH MINISTRY

She argues that ongoing mRNA approvals under his leadership amount to “Crimes Against Humanity.”

NOV 23, 2025

⚡ What aren’t they telling you? Please Join Exposing the Darkness News on Telegram.

Dr. Rima Laibow unloads on RFK Jr., claiming he’s backpedaling on vaccine truth and refusing to use his emergency powers to halt new mRNA authorizations.

Pointing to FDA pipelines and a shift in rhetoric, she asks bluntly:
“What the hell is going on here?”

Source: Sense Receptor

“Just look at the approval of the mRNA vaccines… that’s not, ‘Give him time, he’s working with a complex organization.’ That’s crimes against humanity and complicity.”

Laibow adds, “He’s gotta tiptoe and pussyfoot and condemn children, adults, and old people to illness and death because he’s afraid of somebody? Really?”

This clip of Laibow, a psychiatrist, is taken from an interview with Dr. Bill Lionberger posted to the Vaxxchoice Rumble channel on November 20, 2025.

Partial transcription of clip

“Kennedy allegedly came into his office, his HHS office, on day one already knowing what causes autism. He’s written about it, he’s given interviews, he’s made documentaries, he’s done bus tours, he’s written books. He’s made his mark on that particular issue. And now we hear it’s Tylenol? Okay, so that, that causes my eyebrows to go up as high as the back of my neck.

“Really? It’s Tylenol, is it? Okay. And maybe we’ll take a look at vaccines too, because golly gee, could be something else too, you know, that’s, that’s twinkle toes nonsense. Let’s just look at the mRNA vaccines… I listed all of the vaccines that have been— injections called vaccines, that have been approved since Kennedy took office on the 13th of February. And I listed the ones that are in the pipeline, and there are the FDA pipeline for approval, fast approval, and there are several mRNA and a couple of mRNA replicon ones.

“Well, that’s not, ‘Give him time, he’s working with a complex organization.’ That’s crimes against humanity and complicity. And I don’t understand how you put those two things together. We got a guy who understands all of these things, who’s well informed, who’s been brought up to speed, and who has the power and authority, more power than the President of the United States in terms of health emergency, by the way.

“His declaration of health emergency overrides that of the head of the executive branch of the government of the United States. Immense power. And he’s, he’s gotta tiptoe and pussyfoot and condemn children, adults, and old people to illness and death because he’s afraid of somebody? Really? Oh, gosh, we have to wait while children are rendered autistic, while he’s being afraid of people?

“Were you in that office, would you really condemn children? Would you really condemn old people? Would you really condemn young people to drop dead on the field of play with silent myocarditis from the vaccine that they were assured was safe and effective? No, you would not. And you would take the consequences, run the risk, and do what was right.

Well, what the hell is going on here? You tell me.”

Full Video

 

Study Finds Nattokinase Dissolves 84% of Amyloid Microclots Within 2 Hours In Vitro   NICOLAS HULSCHER, MPH

A natural enzyme potently degrades the same amyloid microclots recently found in 100% of COVID-19 vaccinated individuals tested.

NOV 22, 2025  The Focal Points

As I reported a few days ago, a recent peer-reviewed study revealed a deeply alarming finding: 100% of the vaccinated participants examined had amyloid fibrin(ogen) microclots circulating in their blood.

BREAKING STUDY: Anomalous Amyloid Microclots Found in 100% of the COVID-19 Vaccinated  NICOLAS HULSCHER, MPH  NOV 17, 2025  Read full story

These are the same Thioflavin-T–positive, β-sheet, fibrinolysis-resistant clots now widely observed in Long VACCINE and Long COVID patients due to spike protein exposure. The anomalous microclots also appear to be behind the long white fibrous clots being pulled out of corpses by the majority of embalmers worldwide.

Their presence in every vaccinated individual tested underscores a crisis that the medical establishment has yet to acknowledge — and one that now demands immediate scientific attention.

If they are as widespread as early data suggests, then the most urgent question now becomes: How do we degrade them?

Nattokinase Breaks Down Amyloid Microclots

A recent peer-reviewed study by Grixti et al, published in the Journal of Experimental and Clinical Application of Chinese Medicine, used purified recombinant nattokinase and a high-resolution automated microscopy system to observe exactly what happens when the enzyme directly contacts amyloid fibrin(ogen) microclots.

To generate true amyloid microclots, the researchers mixed fibrinogen with LPS, triggered clot formation with thrombin, and labeled the resulting structures with Thioflavin-T — producing the same β-sheet, ThT-positive fibrinaloid clots seen in human Long COVID and post-vaccine samples.

Nattokinase was then added at two concentrations: 14 µg/mL and 28 µg/mL — levels that fall within the range achievable in humans following high-dose oral administration.

The Results Were Clear and Quantitative

At the higher dose (28 µg/mL), nattokinase reached peak activity at around 2 hours and produced:

• ~84% reduction in total clot number
  (Figure 4A: 920 → 150)
• ~52% reduction in total amyloid fluorescent intensity
  (Figure 4B: 2500 RU → 1200 RU)
• ~20% reduction in median clot size
  (Figure 4C: 15 µm → 12 µm — though this metric underestimates true digestion because the smallest clots disappear first)

At the lower dose (14 µg/mL), nattokinase still produced substantial, dose-dependent effects:

• ~67% reduction in total clot number
  (920 → 300)
• ~20% reduction in total amyloid intensity
  (2500 RU → 2000 RU)
• ~7% reduction in median clot size
  (15 µm → 14 µm)

In other words: nattokinase directly digested amyloid fibrin(ogen) structure.

The authors state this explicitly:

We show that recombinant nattokinase is effective at degrading the fibrinaloid microclots in vitro.

This is the strongest biochemical evidence to date that a natural fibrinolytic enzyme can break down the same amyloid microclots now found in the blood of vaccinated individuals and Long COVID patients.

Potent Dual-Activity

Amyloid fibrin microclots are not ordinary clots. They are structurally misfolded, β-sheet amyloid constructs that resist plasmin, resist rtPA, and trap inflammatory proteins in a dense mesh. Their resistance to dissolution means they can persist in circulation, obstruct capillaries, and contribute to a long list of chronic symptoms.

Adding to this, nattokinase has already been shown in studies to degrade the SARS-CoV-2 spike protein itself (in-vitro) —the same protein that drives amyloid transformation of fibrinogen and accelerates the formation of fibrinaloid microclots. This was one of the primary reasons nattokinase was incorporated into McCullough Protocol Base Spike Detoxification:

This dual activity is significant: nattokinase appears to be able to break down both the trigger (spike) and the pathological result (amyloid microclots). No pharmaceutical thrombolytic therapy has demonstrated this combined effect.

This makes nattokinase one of the few agents with a plausible mechanism to reduce amyloid clot burden without requiring invasive procedures, mechanical devices, or hospital-grade thrombolytics.

Secondary Evidence: Mechanical Clot Destruction via Ultrasound

Alongside this nattokinase study, another recent paper by Rasouli et al demonstrated that amyloid microclots can also be physically fragmented using low-frequency ultrasound, gas microbubbles, and rtPA in a microfluidic vein model. In the strongest condition — low-frequency ultrasound combined with microbubbles and rtPA — large amyloid microclots (>30 µm) were reduced from ~550 to ~20 (Figure 5F), representing a >90% reduction. This demonstrates that cavitation-enhanced ultrasound can physically shatter nearly all large amyloid microclots in a controlled microfluidic model.

However, this approach requires specialized ultrasound equipment, precise acoustic dosing, and close monitoring to avoid cavitation-related tissue damage. While the study clearly shows that amyloid microclots can be mechanically shattered with sufficient low-frequency ultrasound and microbubble–mediated forces, translating such a protocol into human clinical practice would demand extensive safety trials, controlled environments, and expert oversight. These methods may ultimately prove valuable for individuals with severe or refractory amyloid microclot burden.

The Path Forward

If amyloid microclots are present in 100% of COVID-19 vaccinated individuals in some cohorts, then the first priority is determining the true population prevalence. We urgently need large-scale, unbiased studies using standardized Thioflavin-T microscopy, flow cytometry, or advanced microfluidic analysis to map how widespread this pathology is.

Equally urgent is the need for human trials of nattokinase, evaluating:

• pharmacokinetics at different dosing levels
• optimal timing and duration
• real-world effects on amyloid microclot/spike burden
• symptom improvement
• combination strategies with other natural fibrinolytics

The scientific path forward is becoming clear: the amyloid clots can be detected, measured, and in controlled settings, broken down.

Whether the wider scientific community chooses to act on this knowledge will determine how many people suffer long-term consequences from a serious problem that is now plainly visible.

Nicolas Hulscher, MPH   Epidemiologist and Foundation Administrator, McCullough Foundation

Support our mission: mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.

Read previous articles   https://krakennews.us/daily-shmutz-covid-19-malicious-medical-quackery-11-21-25/